Injection of botulinum toxin type a to reduce saliva in patients with neurological diseases

Injection of botulinum toxin type a to reduce saliva in patients with neurological diseases

Objective: To demonstrate the effect of local injection of Botox® inpatients with neurological diseases, following our protocol for thetreatment of sialorrhea. Study design: clinical prospective study.Methods: Twenty-one patients with neurological diseases seen atthe Otorhinolaryngology of the Assoc...

Full description

Bibliographic Details
Main Author:	Dayse Manrique
Format:	Article
Language:	English
Published:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2005-09-01
Series:	Einstein (São Paulo)
Subjects:	Salivary glands Botulinum toxin type A /therapeutic use Sialorrhea/drug therapy Dysphagia Nervous system diseases
Online Access:	http://www.einstein.br/revista/biblioteca/artigos/vol3/num_3/Vol3_N3_P174.pdf

Similar Items

Histological and immunohistochemical findings of the action of botulinum toxin in salivary gland: systematic review
by: J. B. Oliveira, et al.

Intraductal Salivary Gland Infusion With Botulinum Toxin
by: Adam T. Schwalje, et al.
Published: (2019-10-01)

A Double-Blind Randomized Controlled Trial Investigating the Most Efficacious Dose of Botulinum Toxin-A for Sialorrhea Treatment in Asian Adults with Neurological Diseases
by: Mazlina Mazlan, et al.
Published: (2015-09-01)

Application of botulinum toxin to treat sialorrhea in amyotrophic lateral sclerosis patients: a literature review
by: Ademar Francisco de Oliveira Filho, et al.

Therapy of Sialorrhea with Botulinum Neurotoxin
by: Wolfgang H. Jost, et al.
Published: (2019-09-01)

The Effectiveness of Botulinum Toxin Type A Injections in the Management of Sialorrhea
by: Özgür Sürmelioğlu, et al.
Published: (2018-06-01)

The effectiveness of ultrasound‐guided injection of BTX‐A in the management of sialorrhea in neurogenic dysphagia patients
by: Zitong He, et al.
Published: (2023-12-01)

Botulinum Toxin Injections for Treatment of Drooling in Children with Cerebral Palsy: A Systematic Review and Meta-Analysis
by: Shang-An Hung, et al.
Published: (2021-11-01)

The Effects of Botulinum Toxin Type A on Reducing Sialorrhea in Children with Cerebral Palsy: A Self-Controlled Clinical Trial
by: Mehrnaz Nazari Rad, et al.
Published: (2023-12-01)

Therapeutic uses and efficacy of botulinum toxin in orofacial medicine
by: Bayet Kinz, et al.
Published: (2018-01-01)

Ultrasound-guided Botulinum Toxin Injection into the Salivary Glands for Treating Sialorrhea in a Case of Small-cell Lung Cancer
by: Murat Çabalar, et al.
Published: (2023-08-01)

Botulinum toxin in the treatment of sialorrhea
by: Svetel Marina, et al.
Published: (2009-01-01)

Botulinum Toxin, a Drug with Potential Interest for Dentists—An Introduction
by: Merete Bakke
Published: (2022-09-01)

Safety of High-Dose Botulinum Toxin Injections for Parotid and Submandibular Gland Radioprotection
by: Joerg Mueller, et al.
Published: (2022-01-01)

Botulinum Toxin Treatment for Sialorrhea: Evaluation in Patients with Idiopathic Parkinson's Disease
by: Aybala Neslihan Alagöz, et al.
Published: (2020-06-01)

Botulinum Toxin Services for Neurorehabiliation: Recommendations for Challenges and Opportunities during the COVID-19 Pandemic
by: Ganesh Bavikatte, et al.
Published: (2021-08-01)

Combined laryngeal cleft injection laryngoplasty and salivary botulinum toxin for saliva aspiration
by: Justin Nguyen, et al.
Published: (2022-08-01)

Primary treatment of early fistula of parotid duct with botulinum toxin type A injection
by: Camila Ferron, et al.
Published: (2017-12-01)

Comparative Efficacy of Botulinum Toxin in Salivary Glands vs. Oromotor Therapy in the Management of Sialorrhea in Cerebral Palsy Impact on Sleep Quality
by: Juan Francisco Marquez-Vazquez, et al.
Published: (2022-06-01)

Use of Botulinum Toxin in Orofacial Clinical Practice
by: Maria-Angeles Serrera-Figallo, et al.
Published: (2020-02-01)

Successful treatment of post COVID-19 neurogenic dysphagia with botulinum toxin
by: Riccardo Canta, et al.
Published: (2023-11-01)

Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children—update and practice recommendations
by: Wolfgang H. Jost, et al.
Published: (2023-12-01)

Recombinant botulinum toxin as a new stage in the development of botulinum toxin therapy. Possibilities and perspectives of use in neurological practice
by: R. K. Shikhkerimov, et al.
Published: (2022-12-01)

Evaluation of efficacy and safety of Botulinum toxin injection in treatment of epiphora
by: Nashwa A Elshaieb, et al.
Published: (2020-01-01)

The advanced methods of hyperhidrosis treatment using Botulinum toxin
by: Agnieszka Blicharz, et al.
Published: (2022-09-01)

Role of Botulinum toxin injection in neurological problems: A Short Review
by: Isha Dhungana, et al.
Published: (2016-10-01)

Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction
by: Pengxu Wei
Published: (2022-04-01)

Incobotulinumtoxin A for Sialorrhea in Neurological Disorders: A Real-Life Experience
by: Javier Martínez-Poles, et al.
Published: (2018-05-01)

Use of botulinum toxin in hidradenitis suppurativa
by: Elcilane Gomes Silva, et al.
Published: (2021-12-01)

Type a botulinum toxin in the management of spontaneous salivary otorrhea: a case report
by: Teffran J. Chan, et al.
Published: (2020-08-01)

Management of drooling for patients in north of Iran: Analysis and evaluation of 32 patients
by: Seyed Ebrahim Naghavi, et al.
Published: (2010-01-01)

Botulinum Toxin A for Oral Cavity Cancer Patients: In Microsurgical Patients BTX Injections in Major Salivary Glands Temporarily Reduce Salivary Production and the Risk of Local Complications Related to Saliva Stagnation
by: Bartolo Corradino, et al.
Published: (2012-10-01)

Vasculitis with panniculitis following botulinum toxin A injection for cosmetic use
by: Nastaran Namazi, et al.
Published: (2016-01-01)

Treatment of sialorrhea in Parkinson’s disease
by: Sahil Mehta, et al.
Published: (2022-01-01)

Frontal ﬁbrosing alopecia development in two patients after botulinum toxin applications: relationship or coincidence?
by: Mariana Abdo de Almeida, et al.
Published: (2021-12-01)

Botulinum toxin in aesthetic medicine [electronic resource]: /
by: 391545 Maio, Mauricio de, et al.
Published: (2007)

Transient Worsening of Dysphagia and Dysarthria after Treatment with Botulinum Toxin in Patients with Acquired Brain Injury
by: Lucia Francesca Lucca, et al.
Published: (2023-12-01)

Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial
by: Andrew G. Lee, et al.
Published: (2021-01-01)

Specific characteristics of the medical history of swallowing before and after application of botulinum toxin in patients with cervical dystonia
by: Tatiana Fonseca Del Debbio Vilanova, et al.
Published: (2019-04-01)

Treatment of hyperhidrosis and the role of Botulinum Toxin Type A in therapy - a literature review
by: Hugo Szczuraszek, et al.
Published: (2023-03-01)